Rock Springs Capital Management’s Vigil Neuroscience VIGL Stock Holding History

Rock Springs Capital Management’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-471,958	Closed	-$840K	–	101
2025 Q1	$840K	Hold	471,958	–	–	0.05%	90
2024 Q4	$802K	Hold	471,958	–	–	0.03%	101
2024 Q3	$1.6M	Hold	471,958	–	–	0.05%	100
2024 Q2	$1.89M	Hold	471,958	–	–	0.06%	102
2024 Q1	$1.61M	Hold	471,958	–	–	0.04%	109
2023 Q4	$1.6M	Hold	471,958	–	–	0.04%	98
2023 Q3	$2.54M	Hold	471,958	–	–	0.07%	96
2023 Q2	$4.44M	Hold	471,958	–	–	0.11%	89
2023 Q1	$4.62M	Hold	471,958	–	–	0.11%	90
2022 Q4	$5.9M	Hold	471,958	–	–	0.14%	82
2022 Q3	$4.29M	Hold	471,958	–	–	0.11%	97
2022 Q2	$1.22M	Hold	471,958	–	–	0.04%	124
2022 Q1	$3.32M	Buy	+471,958	New	+$6.23M	0.08%	115

Other funds holding VIGL

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

Rock Springs Capital Management's VIGL Position: Q2 2025 in Review

Rock Springs Capital Management sold out of Vigil Neuroscience (VIGL) in Q2 2025, closing a stake of 471,958 shares — an estimated $840K sold.

Rock Springs Capital Management first reported a position in VIGL in Q1 2022 and held it in 13 quarters. The position peaked at $5.9M in Q4 2022. 78 funds tracked by Wall St. Rank hold VIGL as of Q2 2025.

Rock Springs Capital Management reported no remaining Vigil Neuroscience position as of Q2 2025 after selling out during the quarter.
Rock Springs Capital Management sold 471,958 Vigil Neuroscience shares in Q2 2025, an estimated $840K.
Rock Springs Capital Management first reported a position in Vigil Neuroscience in Q1 2022 and held it in 13 quarters.
Rock Springs Capital Management's Vigil Neuroscience position peaked at $5.9M in Q4 2022.
78 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q2 2025.

Based on Rock Springs Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.